Not Yet RecruitingNot Applicable

Enhanced Recovery After Surgery in Hysterectomy Patients

Egypt78 participantsStarted 2026-06-01

Plain-language summary

This prospective randomized controlled clinical trial aims to evaluate the effectiveness of Enhanced Recovery After Surgery (ERAS) protocols in patients undergoing elective hysterectomy. ERAS is an evidence-based perioperative approach designed to reduce surgical stress, accelerate recovery, and improve clinical outcomes. Participants will be randomized to receive either ERAS-based care or conventional perioperative management. The study will assess whether ERAS implementation reduces hospital stay and improves postoperative recovery without increasing complications.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women aged 18-70 years. * Undergoing elective total hysterectomy for benign or early stage malignant gynacological conditions . * ASA ( American Society of Anesthesiologists ) physical status I-II. * Able to provide informed consent. Exclusion Criteria: * Emergency hysterectomy * Advanced malignant requiring extensive debulking * Known bowel disease or previous bowel surgery ( crohn's disease , bowel obstruction ) * Significant cognitive impairment or psychiatric illness * Inability to follow ERAS protocol (e.g., cognitive impairment) * Refusal to participate

What they're measuring

length of hospital stay (LOS)

Timeframe: From day of surgery up to 7 postoperative days

Trial details

NCT IDNCT07564063

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

Contact for this trial

Ehab H Sorour, MD

+201112496821 dr.ehabsorour@gmail.com

View on ClinicalTrials.gov More Enhanced Recovery After Surgery (ERAS) Protocol trials